Povidone-Iodine liposome complex - Mundipharma

Drug Profile

Povidone-Iodine liposome complex - Mundipharma

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mundipharma International
  • Class Antiseptics; Disinfectants; Pyrrolidinones
  • Mechanism of Action DNA inhibitors; Protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Viral infections; Wound infections; Wounds

Most Recent Events

  • 23 Dec 2002 Phase-II clinical trials in Wounds in Germany (Topical)
  • 26 Apr 2001 Preclinical development for Viral infections in Germany (Unknown route)
  • 26 Apr 2001 A preclinical study has been added to the Viral Infections antimicrobial activity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top